| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/12/2007 | US7229614 Interferon gamma in the detection and treatment of angiomyolipomas |
| 06/12/2007 | US7229607 Treatment of respiratory disease |
| 06/12/2007 | CA2484270C Cosmetic use of botulinum toxin for treatment of downturned mouth |
| 06/12/2007 | CA2248772C Novel peptides which inhibit complement activation |
| 06/12/2007 | CA2248710C Conotoxin peptide pviia |
| 06/12/2007 | CA2214649C Antigen presenting system and methods for activation of t-cells |
| 06/12/2007 | CA2184065C Inhibition of arterial smooth muscle cell proliferation |
| 06/12/2007 | CA2173975C Recombinant adenoviral vector and methods of use |
| 06/12/2007 | CA2148252C Interaction trap system for isolating novel proteins |
| 06/12/2007 | CA2122340C Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |
| 06/12/2007 | CA2072620C Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 06/12/2007 | CA2057828C Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines |
| 06/12/2007 | CA2046649C Matrix metalloproteinase inhibitor peptides |
| 06/12/2007 | CA1341530C Inhibitors of angiogenin |
| 06/09/2007 | CA2566267A1 Thymidylate kinase mutants and uses thereof |
| 06/09/2007 | CA2529677A1 Method of modulating gene transcription |
| 06/08/2007 | CA2539874A1 Novel uses of scleraxis |
| 06/07/2007 | WO2007065167A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 06/07/2007 | WO2007065156A2 Pharmaceutical formulation for increased epithelial permeability of glucose-regulating peptide |
| 06/07/2007 | WO2007065147A2 A biomarker of improved intestinal function |
| 06/07/2007 | WO2007065128A2 Human alpha-defensins inhibit interleukin-1beta release |
| 06/07/2007 | WO2007065021A2 A predictive tool for hyaluronidase treatment success |
| 06/07/2007 | WO2007064997A2 Compounds and methods for inhibiting apoptosis |
| 06/07/2007 | WO2007064905A2 Mitigation of photodamage in analytical reactions |
| 06/07/2007 | WO2007064903A1 Fowlicidins and methods of their use |
| 06/07/2007 | WO2007064859A2 Compound and method for suppressing retroviral replication |
| 06/07/2007 | WO2007064844A2 Anti-viral griffithsin compounds, compositions, and methods of use |
| 06/07/2007 | WO2007064800A2 Methods to ameliorate and image angioplasty-induced vascular injury |
| 06/07/2007 | WO2007064647A2 Peptide inhibitors of abl kinases |
| 06/07/2007 | WO2007064634A2 Enterostatin as inhibitor of angiogenesis |
| 06/07/2007 | WO2007064543A1 Hyaluronic acid and hyaluronidase in the enhancement of lens regeneration |
| 06/07/2007 | WO2007064010A1 Preventive/therapeutic agent for alzheimer's dementia |
| 06/07/2007 | WO2007063907A1 Sugar chain adduct of peptide and pharmaceutical comprising the same as active ingredient |
| 06/07/2007 | WO2007063424A2 The modulation of immunity and ceacam1 activity |
| 06/07/2007 | WO2007063299A1 Method for the purification of alpha-1-antitrypsin |
| 06/07/2007 | WO2007063142A1 Protein mixture and use thereof in the preparation of a product that is intended for oral or enteral food |
| 06/07/2007 | WO2007063141A1 Food product for enteral or oral nutrition |
| 06/07/2007 | WO2007063033A1 Process for the production, in prokaryotes, of active, stable transposases of mariner mobile genetic elements |
| 06/07/2007 | WO2007062852A2 ANTI-Aβ GLOBULOMER ANTIBODIES, ANTIGEN-BINDING MOIETIES THEREOF, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCING SAID ANTIBODIES, COMPOSITIONS COMPRISING SAID ANTIBODIES, USES OF SAID ANTIBODIES AND METHODS OF USING SAID ANTIBODIES |
| 06/07/2007 | WO2007062844A1 Chemokine-mucin fusions linked to glycosylphosphatidylinositol (gpi)-anchors in tissue regeneration and as tumour immune adjuvants |
| 06/07/2007 | WO2007062819A2 Multimeric complexes of antigens and an adjuvant |
| 06/07/2007 | WO2007062676A1 Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists |
| 06/07/2007 | WO2007062594A1 Neuregulin variants and methods of screening and using thereof |
| 06/07/2007 | WO2007062531A1 Combination treatments with gastrin agonists for diabetes and related diseases |
| 06/07/2007 | WO2007062528A1 Polycyclic phenolic compounds and use in treating viral infections |
| 06/07/2007 | WO2007062494A1 Orally absorbed pharmaceutical formulation and method of administration |
| 06/07/2007 | WO2007062483A1 Increasing pregnancy rates |
| 06/07/2007 | WO2007062469A1 Methods and compositions for preventing and/or treating pancreatitis |
| 06/07/2007 | WO2007047754A3 Mtor pathway theranostic |
| 06/07/2007 | WO2007043715A9 Rna-binding peptide |
| 06/07/2007 | WO2007041317A3 Immunomodulatory compositions and uses therefor |
| 06/07/2007 | WO2007038395A3 Use of ephrinb2 directed agents for the treatment or prevention of viral infections |
| 06/07/2007 | WO2007028633A3 Treatment of diabetes related obesity |
| 06/07/2007 | WO2007025760A3 Melanoma-associated mhc class i associated oligopeptides and the uses thereof |
| 06/07/2007 | WO2007024723A3 Methods and compositions for treating gastrointestinal radiosensitivity in a subject |
| 06/07/2007 | WO2007024631A3 Botulinum toxin in treatment of clubfoot |
| 06/07/2007 | WO2007024630A3 Botulinum toxin in treatment of clubfoot relapse |
| 06/07/2007 | WO2007023189A3 Pharmaceutical composition and its use for the prophylactic or therapeutic treatment of retroviral diseases |
| 06/07/2007 | WO2007021900A3 Compositions and methods for treating wounds |
| 06/07/2007 | WO2007021572A3 Use of peptides that bind to tpo receptor |
| 06/07/2007 | WO2007012748A3 Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases |
| 06/07/2007 | WO2007012066A3 TRUNCATED OXIDIZED THYMOSIN β4 AND DERIVATIVES THEREOF |
| 06/07/2007 | WO2007002676A3 Liquid protein markers for native gel electrophoresis |
| 06/07/2007 | WO2007000770A3 Protein kinase c inhibitors for prevention of insulin resistance and type 2 diabetes |
| 06/07/2007 | WO2006135846A3 Methods and systems for neural maintenance and regeneration |
| 06/07/2007 | WO2006135660A3 Therapies involving lymphotoxin beta receptor |
| 06/07/2007 | WO2006127907A3 Localized delivery of cardiac inotropic agents |
| 06/07/2007 | WO2006127759A3 Antioxidant supplement composition and method of use |
| 06/07/2007 | WO2006122249A3 Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions |
| 06/07/2007 | WO2006122123A3 Methods of alleviating disorders and their associated pain |
| 06/07/2007 | WO2006121895A3 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| 06/07/2007 | WO2006118805A3 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| 06/07/2007 | WO2006116746A3 Methods and compositions for using alveolar macrophage phospholipase a2 |
| 06/07/2007 | WO2006103354A3 Dermatological and/or cosmetic composition containing proteins of the sirt family |
| 06/07/2007 | WO2006036919A3 Treatment of neurological deficits in the striatum or substanta nigra pars compacta |
| 06/07/2007 | WO2006034249A3 Antimicrobial amorphous compositions |
| 06/07/2007 | WO2005033293A3 Hypoxia - responsive human cngh-0002 genes and polypeptides |
| 06/07/2007 | WO2005020918A3 Ultrasonic concentration of drug delivery capsules |
| 06/07/2007 | WO2004087873A3 Methods of treating xerostomia and xerophthalmia |
| 06/07/2007 | WO2000044335A3 Uridyl peptide antibiotic (upa) derivatives, their synthesis and use |
| 06/07/2007 | US20070130655 and processing of transgenic sugarcane for the recovery of high value proteins; using a nucleic acid encoding the promoter of a sugarcane proline rich protein |
| 06/07/2007 | US20070130629 Renal Regulatory Elements and Methods of Use Thereof |
| 06/07/2007 | US20070129394 Rapamycin conjugated to peptides of up to 10 amino acid units through a carbamate linkage at position 42; coated stents; restenosis, cancer, autoimmune, transplant rejection |
| 06/07/2007 | US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia |
| 06/07/2007 | US20070129314 Treating Type II diabetes comprising coadministering metformin and an inhibitor of dipeptidylpeptidase IV, especially a peptidomimetic containing a pyrrolidine ring in an amount insufficient to suppress the immune system |
| 06/07/2007 | US20070129313 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) |
| 06/07/2007 | US20070129312 Convalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites |
| 06/07/2007 | US20070129311 Compounds comprising two human GlxI inhibitors covalently linked via a diacid where each of the inhibitors may be the same or different and is an S-substituted glutathione or a prodrug thereof having a gamma-glutamyl amino group; length >50 Angstroms; antitumor, -carcinogenic, -proliferative agents |
| 06/07/2007 | US20070129310 Antibacterial agents |
| 06/07/2007 | US20070129309 Conjugates useful in the treatment of prostate cancer |
| 06/07/2007 | US20070129308 Method and peptide for regulating cellular activity |
| 06/07/2007 | US20070129307 Insulin epitopes for the treatment of type 1 diabetes |
| 06/07/2007 | US20070129306 Methods for Reducing CD36 Expression |
| 06/07/2007 | US20070129305 Cell penetrating peptides for intracellular delivery of molecules |
| 06/07/2007 | US20070129304 Glucagon-like peptide receptor agonists |
| 06/07/2007 | US20070129303 culture product protein obtained from culturing kidney epithelial cells of BSC-1 African green monkey kidney epithelial cell line; for perfusing ex vivo a donor human kidney, intended for transplantation into a new host; treating and diagnosing patients with kidney disease |
| 06/07/2007 | US20070129302 Il-17c antagonists and methods of using the same |
| 06/07/2007 | US20070129301 Methods and compositions for modulating hgf/met |
| 06/07/2007 | US20070129300 Cytotoxic factors for modulating cell death |
| 06/07/2007 | US20070129299 Compositions and methods for enhanced mucosal delivery of pyy peptide |